Skip to content

Questionnaire survey of patients and physicians for Early-stage hepatocellular carcinoma

Questionnaire survey of patients and physicians for Early-stage hepatocellular carcinoma - Questionnaire survey of patients and physicians for Early-stage hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Unknown
Source
JPRN
Registry ID
JPRN-UMIN000049847
Enrollment
200
Registered
2022-12-22
Start date
2022-12-23
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma

Interventions

None listed

Sponsors

Ono Pharmaceutical Co., Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Patients 1. Aged less than 20years 2.Residents of Japan who received locoregional therapy for hepatocellular carcinoma (hepatectomy or ablation) more than two times 3.Within 5 years of last locoregional therapy (hepatectomy or ablation) 4.Signed informed consent form Physicians 1.Licensed Japanese medical doctors who performed an average of at least 5cases/year of hepatectomy or ablation within 5 years 2.At least five cases of hepatectomy or ablation in the last year 3.Signed informed consent form

Exclusion criteria

Exclusion criteria: Patients who are engaged in a pharmaceutical, medical, or survey-related job

Design outcomes

Primary

MeasureTime frame
Well-being and the factors associated with well-being changes in patients with Early-stage hepatocellular carcinoma

Secondary

MeasureTime frame
To clarify the important things for patients in locoregional therapy and adjuvant therapy from the views of patients who received locoregional therapy and physicians who performed locoregional therapy, respectively.

Countries

Japan

Contacts

Public ContactAnri Watanabe

3H Clinical Trial Co., Ltd. Insight & Outcome Group

a-watanabe@3h-ct.co.jp03-5985-0053

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026